[11C]CPPC

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug Name[11C]CPPC
Drug Alias NameN/A
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionColony stimulating factor 1 receptor modulators
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsPost-Acute COVID-19 SyndromeAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 SyndromeAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A